Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...